vs
KLA Corporation（KLAC）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是KLA Corporation的1.7倍（$5.5B vs $3.3B），KLA Corporation净利率更高（34.7% vs 11.7%，领先23.1%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 7.2%），KLA Corporation自由现金流更多（$1.3B vs $367.0M），过去两年KLA Corporation的营收复合增速更高（18.2% vs 1.5%）
KLA Corporation是总部位于美国加利福尼亚州米尔皮塔斯的企业，主营晶圆制造设备，为半导体及相关纳米电子行业提供过程控制与良率管理系统，产品及服务覆盖晶圆、光罩、集成电路、封装生产从研发到批量制造的全流程。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
KLAC vs THC — 直观对比
营收规模更大
THC
是对方的1.7倍
$3.3B
营收增速更快
THC
高出1.8%
7.2%
净利率更高
KLAC
高出23.1%
11.7%
自由现金流更多
KLAC
多$895.0M
$367.0M
两年增速更快
KLAC
近两年复合增速
1.5%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.3B | $5.5B |
| 净利润 | $1.1B | $644.0M |
| 毛利率 | 61.4% | — |
| 营业利润率 | — | 15.4% |
| 净利率 | 34.7% | 11.7% |
| 营收同比 | 7.2% | 9.0% |
| 净利润同比 | 39.0% | 12.6% |
| 每股收益（稀释后） | $8.68 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KLACTHC
| Q4 25 | $3.3B | $5.5B | ||
| Q3 25 | $3.2B | $5.3B | ||
| Q2 25 | $3.2B | $5.3B | ||
| Q1 25 | $3.1B | $5.2B | ||
| Q4 24 | $3.1B | $5.1B | ||
| Q3 24 | $2.8B | $5.1B | ||
| Q2 24 | $2.6B | $5.1B | ||
| Q1 24 | $2.4B | $5.4B |
净利润KLACTHC
| Q4 25 | $1.1B | $644.0M | ||
| Q3 25 | $1.1B | $579.0M | ||
| Q2 25 | $1.2B | $522.0M | ||
| Q1 25 | $1.1B | $622.0M | ||
| Q4 24 | $824.5M | $572.0M | ||
| Q3 24 | $945.9M | $681.0M | ||
| Q2 24 | $836.4M | $477.0M | ||
| Q1 24 | $601.5M | $2.3B |
毛利率KLACTHC
| Q4 25 | 61.4% | — | ||
| Q3 25 | 61.3% | — | ||
| Q2 25 | 62.0% | — | ||
| Q1 25 | 61.6% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 59.6% | — | ||
| Q2 24 | 60.7% | — | ||
| Q1 24 | 57.9% | — |
营业利润率KLACTHC
| Q4 25 | — | 15.4% | ||
| Q3 25 | — | 16.8% | ||
| Q2 25 | 41.9% | 15.6% | ||
| Q1 25 | 41.3% | 18.1% | ||
| Q4 24 | 31.6% | 16.2% | ||
| Q3 24 | 38.0% | 21.3% | ||
| Q2 24 | 36.8% | 14.9% | ||
| Q1 24 | 29.7% | 61.2% |
净利率KLACTHC
| Q4 25 | 34.7% | 11.7% | ||
| Q3 25 | 34.9% | 10.9% | ||
| Q2 25 | 37.9% | 9.9% | ||
| Q1 25 | 35.5% | 11.9% | ||
| Q4 24 | 26.8% | 11.3% | ||
| Q3 24 | 33.3% | 13.3% | ||
| Q2 24 | 32.6% | 9.3% | ||
| Q1 24 | 25.5% | 43.5% |
每股收益（稀释后）KLACTHC
| Q4 25 | $8.68 | $4.22 | ||
| Q3 25 | $8.47 | $3.86 | ||
| Q2 25 | $9.04 | $3.14 | ||
| Q1 25 | $8.16 | $4.27 | ||
| Q4 24 | $6.16 | $3.79 | ||
| Q3 24 | $7.01 | $4.89 | ||
| Q2 24 | $6.16 | $2.64 | ||
| Q1 24 | $4.43 | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5B | $2.9B |
| 总债务越低越好 | $5.9B | $13.1B |
| 股东权益账面价值 | $5.5B | $4.2B |
| 总资产 | $16.7B | $29.7B |
| 负债/权益比越低杠杆越低 | 1.08× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资KLACTHC
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | $1.9B | $3.0B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $1.9B | $3.0B | ||
| Q4 24 | $1.8B | $3.0B | ||
| Q3 24 | $2.0B | $4.1B | ||
| Q2 24 | $2.0B | $2.9B | ||
| Q1 24 | $1.8B | $2.5B |
总债务KLACTHC
| Q4 25 | $5.9B | $13.1B | ||
| Q3 25 | $5.9B | $13.1B | ||
| Q2 25 | $5.9B | $13.1B | ||
| Q1 25 | $5.9B | $13.1B | ||
| Q4 24 | $5.9B | $13.1B | ||
| Q3 24 | $5.9B | $12.8B | ||
| Q2 24 | $5.9B | $12.8B | ||
| Q1 24 | $5.9B | $12.8B |
股东权益KLACTHC
| Q4 25 | $5.5B | $4.2B | ||
| Q3 25 | $5.0B | $4.0B | ||
| Q2 25 | $4.7B | $3.7B | ||
| Q1 25 | $4.0B | $4.2B | ||
| Q4 24 | $3.6B | $4.2B | ||
| Q3 24 | $3.6B | $3.8B | ||
| Q2 24 | $3.4B | $3.5B | ||
| Q1 24 | $3.1B | $3.5B |
总资产KLACTHC
| Q4 25 | $16.7B | $29.7B | ||
| Q3 25 | $16.3B | $29.4B | ||
| Q2 25 | $16.1B | $28.7B | ||
| Q1 25 | $15.2B | $29.2B | ||
| Q4 24 | $15.0B | $28.9B | ||
| Q3 24 | $15.7B | $29.4B | ||
| Q2 24 | $15.4B | $29.3B | ||
| Q1 24 | $15.0B | $28.9B |
负债/权益比KLACTHC
| Q4 25 | 1.08× | 3.10× | ||
| Q3 25 | 1.18× | 3.26× | ||
| Q2 25 | 1.25× | 3.49× | ||
| Q1 25 | 1.47× | 3.13× | ||
| Q4 24 | 1.64× | 3.14× | ||
| Q3 24 | 1.65× | 3.33× | ||
| Q2 24 | 1.75× | 3.67× | ||
| Q1 24 | 1.90× | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.4B | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $1.3B | $367.0M |
| 自由现金流率自由现金流/营收 | 38.3% | 6.6% |
| 资本支出强度资本支出/营收 | 3.2% | 6.6% |
| 现金转化率经营现金流/净利润 | 1.19× | 1.14× |
| 过去12个月自由现金流最近4个季度 | $4.4B | $2.5B |
8季度趋势，按日历期对齐
经营现金流KLACTHC
| Q4 25 | $1.4B | $731.0M | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $936.0M | ||
| Q1 25 | $1.1B | $815.0M | ||
| Q4 24 | $849.5M | $-331.0M | ||
| Q3 24 | $995.2M | $1.0B | ||
| Q2 24 | $892.6M | $747.0M | ||
| Q1 24 | $910.0M | $586.0M |
自由现金流KLACTHC
| Q4 25 | $1.3B | $367.0M | ||
| Q3 25 | $1.1B | $778.0M | ||
| Q2 25 | $1.1B | $743.0M | ||
| Q1 25 | $990.0M | $642.0M | ||
| Q4 24 | $757.2M | $-661.0M | ||
| Q3 24 | $934.8M | $829.0M | ||
| Q2 24 | $831.9M | $602.0M | ||
| Q1 24 | $838.2M | $346.0M |
自由现金流率KLACTHC
| Q4 25 | 38.3% | 6.6% | ||
| Q3 25 | 33.2% | 14.7% | ||
| Q2 25 | 33.5% | 14.1% | ||
| Q1 25 | 32.3% | 12.3% | ||
| Q4 24 | 24.6% | -13.0% | ||
| Q3 24 | 32.9% | 16.2% | ||
| Q2 24 | 32.4% | 11.8% | ||
| Q1 24 | 35.5% | 6.4% |
资本支出强度KLACTHC
| Q4 25 | 3.2% | 6.6% | ||
| Q3 25 | 3.0% | 5.3% | ||
| Q2 25 | 3.2% | 3.7% | ||
| Q1 25 | 2.7% | 3.3% | ||
| Q4 24 | 3.0% | 6.5% | ||
| Q3 24 | 2.1% | 4.2% | ||
| Q2 24 | 2.4% | 2.8% | ||
| Q1 24 | 3.0% | 4.5% |
现金转化率KLACTHC
| Q4 25 | 1.19× | 1.14× | ||
| Q3 25 | 1.04× | 1.83× | ||
| Q2 25 | 0.97× | 1.79× | ||
| Q1 25 | 0.99× | 1.31× | ||
| Q4 24 | 1.03× | -0.58× | ||
| Q3 24 | 1.05× | 1.53× | ||
| Q2 24 | 1.07× | 1.57× | ||
| Q1 24 | 1.51× | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KLAC
| Wafer Inspection | $1.6B | 48% |
| Services | $786.1M | 24% |
| Patterning | $696.2M | 21% |
| Specialty Semiconductor Process | $121.6M | 4% |
| PCB And Component Inspection | $80.3M | 2% |
| Other Revenue | $40.2M | 1% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
